We hypothesized that the following parameters may possibly have an impact: duration of antiretroviral therapy, timing of therapy initiation (≤60 after infection or later, as described in [22]), and pre-treatment levels of HIV-DNA and CD4 cell counts. The gene discussed is CD4; the disease is infection.